How many insider declarations does 立方制药 have?

立方制药 has filed 11 insider declarations with AMF.

Who is the top reporting insider at 立方制药?

The top reporting insider at 立方制药 is 汪琴, based on the count of public filings.

What is the net insider buy vs sell volume on 立方制药?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

立方制药: directors' dealings · France · AMF

SZSE:003020FR·AMFMcap 4.9Bn€

AMF ↗

Explore the full insider trade history of 立方制药, a listed equity based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €4.9bn. The latest transaction was reported on 21 June 2023 — Sale. Among the most active insiders: 汪琴. All data is openly available.

11

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

11 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

21.21 €

Income statement

Revenue1.55 Bn€

Gross profit1.00 Bn€65% margin

Net income165.2 M€10.6% margin

Balance sheet & cash

Market cap4.92 Bn€

Total debt63.9 M€

Free Cash Flow94.4 M€

Last declaration on 21 June 2023

All Executives11 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations